logo
Share SHARE
FONT-SIZE Plus   Neg

Strategic Diagnostics Turns To Profit In Q4

Strategic Diagnostics (SDIX), a biotechnology-based products provider, reported fourth-quarter net income of $1.7 million or $0.08 per share, compared to a net loss of $260,000 or $0.01 per share last year.

Results for the quarter included income from discontinued operations of $3.2 million

Revenues for the quarter declined to $5.5 million from $6.3 million last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Tesla's next electric car Model 3 is aimed at the masses with a price tag that could go below $30,000. Tesla CEO Elon Musk, during an earnings call, confirmed that the Model 3 will start selling for "around $35k," and reservations will start from March 31 in Tesla stores and online on April 1 for... Advanced Disposal Services Inc. joins the growing list of companies to postpone their initial public offering amid the volatility in stock markets. Breakfast and snack food giant Kellogg Co. on Thursday reported a loss for the fourth quarter that narrowed from last year as lower revenues were more than offset by a decline in costs and expenses. Adjusted earnings per share for the quarter topped analysts' estimates, while revenue fell short of expectations. Looking ahead, the company affirmed its financial outlook for fiscal 2016.
comments powered by Disqus
Follow RTT